Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ultragenyx Pharmaceutical (RARE) Inventory Average (2018 - 2025)

Ultragenyx Pharmaceutical (RARE) has disclosed Inventory Average for 8 consecutive years, with $52.1 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 17.96% to $52.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.1 million through Dec 2025, up 17.96% year-over-year, with the annual reading at $48.5 million for FY2025, 22.83% up from the prior year.
  • Inventory Average for Q4 2025 was $52.1 million at Ultragenyx Pharmaceutical, up from $49.3 million in the prior quarter.
  • The five-year high for Inventory Average was $52.1 million in Q4 2025, with the low at $12.8 million in Q1 2021.
  • Average Inventory Average over 5 years is $30.4 million, with a median of $28.7 million recorded in 2023.
  • The sharpest move saw Inventory Average grew 11.3% in 2021, then soared 56.82% in 2023.
  • Over 5 years, Inventory Average stood at $15.7 million in 2021, then soared by 54.72% to $24.3 million in 2022, then soared by 35.29% to $32.9 million in 2023, then skyrocketed by 34.31% to $44.2 million in 2024, then grew by 17.96% to $52.1 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $52.1 million, $49.3 million, and $46.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.